City National Bank’s Puma Biotechnology PBYI Stock Holding History

City National Bank’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-5,500	Closed	-$569K	–	856
2013 Q4	$569K	Buy	+5,500	New	+$323K	0.01%	538

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

City National Bank's PBYI Position: Q1 2014 in Review

City National Bank sold out of Puma Biotechnology (PBYI) in Q1 2014, closing a stake of 5,500 shares — an estimated $569K sold.

City National Bank first reported a position in PBYI in Q4 2013 and held it in 1 quarter. The position peaked at $569K in Q4 2013. 138 funds tracked by Wall St. Rank hold PBYI as of Q1 2014.

City National Bank reported no remaining Puma Biotechnology position as of Q1 2014 after selling out during the quarter.
City National Bank sold 5,500 Puma Biotechnology shares in Q1 2014, an estimated $569K.
City National Bank first reported a position in Puma Biotechnology in Q4 2013 and held it in 1 quarter.
City National Bank's Puma Biotechnology position peaked at $569K in Q4 2013.
138 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2014.

Based on City National Bank's 13F filing for Q1 2014, filed 2 May 2014.